Dynamic changes in clinical features and cytokine/chemokine responses in SARS patients treated with interferon alfacon-1 plus corticosteroids
Severe acute respiratory syndrome (SARS), caused by a novel coronavirus, emerged in early 2003 as a major international health crisis. We report on serum cytokine levels, viral load and clinical parameters over the course of the disease in a cohort of nine adult SARS patients treated with steroids and interferon alfacon-1 at North York General Hospital in Toronto, Ontario. Considerable variation among SARS patients with respect to circulating viral load and patterns of SARS-CoV-evoked cytokine responses was recorded. No single cytokine profile was observed in all patients, yet serum concentrations of interferon (IFN)-gamma, interleukin (IL)-10, CXCL10, CCL5 and CXCL8 were found to be elevated above normal levels during the course of the disease in all patients. Expression levels for IL-10, IFN-gamma and CXCL10 consistently peaked within 4 days of peak viral load. IL-12p70, IL-4 and tumour necrosis factor-alpha concentrations were consistently highest within 5 days of peak viral load. These results suggest that elevated levels of inflammatory cytokines are sensitive correlates of disease severity, including lung abnormalities and viral load in serum, and may provide a tool for monitoring disease progression in affected individuals.
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2005 |
|---|---|
| Erschienen: |
2005 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:10 |
|---|---|
| Enthalten in: |
Antiviral therapy - 10(2005), 2 vom: 15., Seite 263-75 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Ward, Sarah E [VerfasserIn] |
|---|
| Anmerkungen: |
Date Completed 29.07.2005 Date Revised 24.11.2016 published: Print Citation Status MEDLINE |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
NLM155129694 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM155129694 | ||
| 003 | DE-627 | ||
| 005 | 20231223071451.0 | ||
| 007 | tu | ||
| 008 | 231223s2005 xx ||||| 00| ||eng c | ||
| 028 | 5 | 2 | |a pubmed24n0517.xml |
| 035 | |a (DE-627)NLM155129694 | ||
| 035 | |a (NLM)15865221 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Ward, Sarah E |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Dynamic changes in clinical features and cytokine/chemokine responses in SARS patients treated with interferon alfacon-1 plus corticosteroids |
| 264 | 1 | |c 2005 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a Date Completed 29.07.2005 | ||
| 500 | |a Date Revised 24.11.2016 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Severe acute respiratory syndrome (SARS), caused by a novel coronavirus, emerged in early 2003 as a major international health crisis. We report on serum cytokine levels, viral load and clinical parameters over the course of the disease in a cohort of nine adult SARS patients treated with steroids and interferon alfacon-1 at North York General Hospital in Toronto, Ontario. Considerable variation among SARS patients with respect to circulating viral load and patterns of SARS-CoV-evoked cytokine responses was recorded. No single cytokine profile was observed in all patients, yet serum concentrations of interferon (IFN)-gamma, interleukin (IL)-10, CXCL10, CCL5 and CXCL8 were found to be elevated above normal levels during the course of the disease in all patients. Expression levels for IL-10, IFN-gamma and CXCL10 consistently peaked within 4 days of peak viral load. IL-12p70, IL-4 and tumour necrosis factor-alpha concentrations were consistently highest within 5 days of peak viral load. These results suggest that elevated levels of inflammatory cytokines are sensitive correlates of disease severity, including lung abnormalities and viral load in serum, and may provide a tool for monitoring disease progression in affected individuals | ||
| 650 | 4 | |a Comparative Study | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 7 | |a Adrenal Cortex Hormones |2 NLM | |
| 650 | 7 | |a Antiviral Agents |2 NLM | |
| 650 | 7 | |a CCL5 protein, human |2 NLM | |
| 650 | 7 | |a Chemokine CCL5 |2 NLM | |
| 650 | 7 | |a Chemokine CXCL10 |2 NLM | |
| 650 | 7 | |a Chemokines, CC |2 NLM | |
| 650 | 7 | |a Chemokines, CXC |2 NLM | |
| 650 | 7 | |a Cytokines |2 NLM | |
| 650 | 7 | |a Glucocorticoids |2 NLM | |
| 650 | 7 | |a Interferon Type I |2 NLM | |
| 650 | 7 | |a Interferon-alpha |2 NLM | |
| 650 | 7 | |a Recombinant Proteins |2 NLM | |
| 650 | 7 | |a interferon alfacon-1 |2 NLM | |
| 650 | 7 | |a 56588OP40D |2 NLM | |
| 650 | 7 | |a Interferon-gamma |2 NLM | |
| 650 | 7 | |a 82115-62-6 |2 NLM | |
| 650 | 7 | |a Prednisone |2 NLM | |
| 650 | 7 | |a VB0R961HZT |2 NLM | |
| 650 | 7 | |a Methylprednisolone |2 NLM | |
| 650 | 7 | |a X4W7ZR7023 |2 NLM | |
| 700 | 1 | |a Loutfy, Mona R |e verfasserin |4 aut | |
| 700 | 1 | |a Blatt, Lawrence M |e verfasserin |4 aut | |
| 700 | 1 | |a Siminovitch, Katharine A |e verfasserin |4 aut | |
| 700 | 1 | |a Chen, Jiabing |e verfasserin |4 aut | |
| 700 | 1 | |a Hinek, Anna |e verfasserin |4 aut | |
| 700 | 1 | |a Wolff, Bryan |e verfasserin |4 aut | |
| 700 | 1 | |a Pham, Dieu H |e verfasserin |4 aut | |
| 700 | 1 | |a Deif, Hassan |e verfasserin |4 aut | |
| 700 | 1 | |a LaMere, Elizabeth A |e verfasserin |4 aut | |
| 700 | 1 | |a Kain, Kevin C |e verfasserin |4 aut | |
| 700 | 1 | |a Farcas, Gabriella A |e verfasserin |4 aut | |
| 700 | 1 | |a Ferguson, Patti |e verfasserin |4 aut | |
| 700 | 1 | |a Latchford, Mary |e verfasserin |4 aut | |
| 700 | 1 | |a Levy, Gary |e verfasserin |4 aut | |
| 700 | 1 | |a Fung, Liasum |e verfasserin |4 aut | |
| 700 | 1 | |a Dennis, James W |e verfasserin |4 aut | |
| 700 | 1 | |a Lai, Enoch K Y |e verfasserin |4 aut | |
| 700 | 1 | |a Fish, Eleanor N |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Antiviral therapy |d 1996 |g 10(2005), 2 vom: 15., Seite 263-75 |w (DE-627)NLM097535710 |x 2040-2058 |7 nnns |
| 773 | 1 | 8 | |g volume:10 |g year:2005 |g number:2 |g day:15 |g pages:263-75 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 10 |j 2005 |e 2 |b 15 |h 263-75 | ||